logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Franklin, Alan Graham
    Architect born in October 1957
    Individual (18 offsprings)
    Officer
    icon of calendar 2018-01-18 ~ dissolved
    OF - Director → CIF 0
    Alan Graham Franklin
    Born in October 1957
    Individual (18 offsprings)
    Person with significant control
    icon of calendar 2018-01-18 ~ dissolved
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

FDA DEVELOPMENTS LIMITED

Standard Industrial Classification
68100 - Buying And Selling Of Own Real Estate
Brief company account
Par Value of Share
Class 1 ordinary share
12021-02-01 ~ 2022-07-31
Total Inventories
428,644 GBP2021-01-31
Cash at bank and in hand
6,079 GBP2022-07-31
2,865 GBP2021-01-31
Current Assets
6,079 GBP2022-07-31
431,509 GBP2021-01-31
Creditors
Current
7,995 GBP2022-07-31
549,878 GBP2021-01-31
Net Current Assets/Liabilities
-1,916 GBP2022-07-31
-118,369 GBP2021-01-31
Total Assets Less Current Liabilities
-1,916 GBP2022-07-31
-118,369 GBP2021-01-31
Equity
Called up share capital
100 GBP2022-07-31
100 GBP2021-01-31
Retained earnings (accumulated losses)
-2,016 GBP2022-07-31
-118,469 GBP2021-01-31
Equity
-1,916 GBP2022-07-31
-118,369 GBP2021-01-31
Average Number of Employees
12021-02-01 ~ 2022-07-31
12020-02-01 ~ 2021-01-31
Bank Borrowings/Overdrafts
Current
282,045 GBP2021-01-31
Trade Creditors/Trade Payables
Current
5,033 GBP2022-07-31
5,033 GBP2021-01-31
Amounts owed to group undertakings
Current
2,062 GBP2022-07-31
Other Creditors
Current
900 GBP2022-07-31
262,800 GBP2021-01-31
Bank Borrowings
Secured
282,045 GBP2021-01-31
Total Borrowings
Secured
482,045 GBP2021-01-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2022-07-31

Related profiles found in government register
  • FDA DEVELOPMENTS LIMITED
    Info
    Registered number 11157323
    icon of addressC/o Mgb Accountants - Suite 22 Trym Lodge, 1 Henbury Road, Westbury-on-trym, Bristol BS9 3HQ
    PRIVATE LIMITED COMPANY incorporated on 2018-01-18 and dissolved on 2024-12-10 (6 years 10 months). The company status is Dissolved.
    The last date of confirmation statement was made at 2023-01-18
    CIF 0
  • FDA DEVELOPMENTS LIMITED
    S
    Registered number 11157323
    icon of addressPortwall Place, Portwall Lane, Bristol, United Kingdom, BS1 6NA
    Limited in Companies House, United Kingdom
    CIF 1
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
Ceased 1
  • icon of address4 Moor Park Court, Moor Park, Clevedon, Somerset, England
    Active Corporate (5 parents)
    Equity (Company account)
    0 GBP2024-01-31
    Person with significant control
    icon of calendar 2019-08-29 ~ 2023-01-01
    CIF 1 - Right to appoint or remove directors OE
    CIF 1 - Ownership of voting rights - 75% or more OE

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.